In this real‑world multicenter study (Wenzhou, China), 113 chronic hepatitis C patients received colbopasvir (60 mg) + sofosbuvir (400 mg) daily for 12 weeks. Overall SVR12 was 99.1% (112/113). SVR12 ...

Fifteen years ago, doctors in Europe noticed a remarkable thing happening in people with chronic hepatitis B infections. When ...

A new state dashboard of school vaccine rates shows Cincinnati Public Schools is far behind other urban districts. The ...

Diwan, PhD, President and Executive Chairman of the Company, adding, "Physicians in charge could have sought it under ...

The developments come as the Trump administration sees a marked rise in the influence of anti-vaccine figures and movements, ...

Kennedy touts MAHA. This Mother's Day, note what his misinformation and policies really do to moms: reduce access to care, ...

In a Truth Social post announcing his next surgeon general nominee, President Donald Trump praised Dr. Nicole Saphier as "an INCREDIBLE communicator" who breaks down complex health issues for ...

The biolab in Reedley was shut down after investigators found dozens of freezers and refrigerators full of bacterial, viral ...

The Food and Drug Administration blocked the publication of studies that tracked the safety of the COVID-19 and shingles ...

Direct Relief and The Pfizer Foundation announced today new grantees for their infectious disease program, awarding $4.5 ...